Pulsatile perfusion bioreactor for cardiac tissue engineering.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 19194900)

Published in Biotechnol Prog on February 05, 2009

Authors

Melissa A Brown1, Rohin K Iyer, Milica Radisic

Author Affiliations

1: Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada.

Articles citing this

Challenges in cardiac tissue engineering. Tissue Eng Part B Rev (2010) 1.66

Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface (2011) 1.13

Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement. PLoS One (2012) 1.08

Optimization of electrical stimulation parameters for cardiac tissue engineering. J Tissue Eng Regen Med (2011) 1.02

Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J Tissue Eng Regen Med (2011) 0.99

Enrichment of live unlabelled cardiomyocytes from heterogeneous cell populations using manipulation of cell settling velocity by magnetic field. Biomicrofluidics (2013) 0.98

Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model. Tissue Eng Part A (2014) 0.97

Fundamentals and application of magnetic particles in cell isolation and enrichment: a review. Rep Prog Phys (2014) 0.86

Engineered cardiac tissues. Curr Opin Biotechnol (2011) 0.85

Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research. Heart Fail Rev (2014) 0.83

Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles. Ann Biomed Eng (2013) 0.83

Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation. Biofabrication (2014) 0.82

Biofabrication enables efficient interrogation and optimization of sequential culture of endothelial cells, fibroblasts and cardiomyocytes for formation of vascular cords in cardiac tissue engineering. Biofabrication (2012) 0.82

Current status of stem cell therapy in heart failure. Curr Cardiol Rep (2010) 0.81

Dynamic culture yields engineered myocardium with near-adult functional output. Biomaterials (2016) 0.81

Mechanostimulation protocols for cardiac tissue engineering. Biomed Res Int (2013) 0.80

A novel pulsatile bioreactor for mechanical stimulation of tissue engineered cardiac constructs. J Funct Biomater (2011) 0.79

Cardiac fibroblasts inhibit β-adrenoceptor-dependent connexin43 expression in neonatal rat cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.76

Electrical and mechanical stimulation of cardiac cells and tissue constructs. Adv Drug Deliv Rev (2015) 0.76

Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review. Int J Mol Cell Med (2012) 0.75

Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs. Crit Rev Biomed Eng (2015) 0.75

Articles by these authors

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14

Electrical stimulation systems for cardiac tissue engineering. Nat Protoc (2009) 1.97

A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A (2012) 1.95

Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng (2010) 1.82

Challenges in cardiac tissue engineering. Tissue Eng Part B Rev (2010) 1.66

Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng (2005) 1.48

Microfluidic patterning for fabrication of contractile cardiac organoids. Biomed Microdevices (2007) 1.46

Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration. J Am Coll Cardiol (2012) 1.42

Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng (2006) 1.41

Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater (2008) 1.34

Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials (2009) 1.31

Biomimetic approach to tissue engineering. Semin Cell Dev Biol (2008) 1.30

Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci U S A (2013) 1.29

Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials (2007) 1.23

Biphasic electrical field stimulation aids in tissue engineering of multicell-type cardiac organoids. Tissue Eng Part A (2008) 1.20

Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials (2010) 1.19

Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering. J Biomed Mater Res A (2009) 1.16

Peptide-mediated selective adhesion of smooth muscle and endothelial cells in microfluidic shear flow. Langmuir (2007) 1.13

Practical aspects of cardiac tissue engineering with electrical stimulation. Methods Mol Med (2007) 1.11

Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc Natl Acad Sci U S A (2009) 1.10

Deterministic lateral displacement as a means to enrich large cells for tissue engineering. Anal Chem (2009) 1.09

Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip (2008) 1.08

Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement. PLoS One (2012) 1.08

Photocrosslinkable hydrogel for myocyte cell culture and injection. J Biomed Mater Res B Appl Biomater (2007) 1.06

Controlled capture and release of cardiac fibroblasts using peptide-functionalized alginate gels in microfluidic channels. Lab Chip (2009) 1.04

Perfusable branching microvessel bed for vascularization of engineered tissues. Proc Natl Acad Sci U S A (2012) 1.04

Micro- and nanotechnology in cell separation. Int J Nanomedicine (2006) 1.02

Effects of electrical stimulation in C2C12 muscle constructs. J Tissue Eng Regen Med (2008) 0.99

A photolithographic method to create cellular micropatterns. Biomaterials (2006) 0.95

Optical mapping of impulse propagation in engineered cardiac tissue. Tissue Eng Part A (2009) 0.93

Size-based microfluidic enrichment of neonatal rat cardiac cell populations. Biomed Microdevices (2006) 0.93

Microfluidic depletion of endothelial cells, smooth muscle cells, and fibroblasts from heterogeneous suspensions. Lab Chip (2008) 0.93

Micro- and nanotechnology in cardiovascular tissue engineering. Nanotechnology (2011) 0.92

In situ mechanical characterization of the cell nucleus by atomic force microscopy. ACS Nano (2014) 0.90

Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med (2010) 0.90

Endothelial cells guided by immobilized gradients of vascular endothelial growth factor on porous collagen scaffolds. Acta Biomater (2011) 0.89

A novel composite scaffold for cardiac tissue engineering. In Vitro Cell Dev Biol Anim (2005) 0.89

Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. J Biomed Mater Res A (2010) 0.88

Bioactive scaffolds for engineering vascularized cardiac tissues. Macromol Biosci (2010) 0.88

Spatiotemporal tracking of cells in tissue-engineered cardiac organoids. J Tissue Eng Regen Med (2009) 0.88

Stem cell-based cardiac tissue engineering. J Cardiovasc Transl Res (2011) 0.88

Biomaterial based cardiac tissue engineering and its applications. Biomed Mater (2015) 0.88

Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. Lab Chip (2014) 0.87

A peptide-modified chitosan-collagen hydrogel for cardiac cell culture and delivery. Acta Biomater (2011) 0.87

Vascular endothelial growth factor secretion by nonmyocytes modulates Connexin-43 levels in cardiac organoids. Tissue Eng Part A (2012) 0.87

Feasibility study of a novel urinary bladder bioreactor. Tissue Eng Part A (2008) 0.87

Engineered heart tissue enables study of residual undifferentiated embryonic stem cell activity in a cardiac environment. Biotechnol Bioeng (2010) 0.86

Mosaic hydrogels: one-step formation of multiscale soft materials. Adv Mater (2012) 0.86

Engineered cardiac tissues. Curr Opin Biotechnol (2011) 0.85

Controlled release of thymosin β4 using collagen-chitosan composite hydrogels promotes epicardial cell migration and angiogenesis. J Control Release (2011) 0.85

Engineering of oriented myocardium on three-dimensional micropatterned collagen-chitosan hydrogel. Int J Artif Organs (2012) 0.83

Topological and electrical control of cardiac differentiation and assembly. Stem Cell Res Ther (2013) 0.83

Cell seeding of polymer scaffolds. Methods Mol Biol (2004) 0.83

Biophysical regulation during cardiac development and application to tissue engineering. Int J Dev Biol (2006) 0.83

Mitochondrial hyperfusion during oxidative stress is coupled to a dysregulation in calcium handling within a C2C12 cell model. PLoS One (2013) 0.82

Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation. Biofabrication (2014) 0.82

Cardiac tissue engineering: current state and perspectives. Front Biosci (Landmark Ed) (2012) 0.82

Biofabrication enables efficient interrogation and optimization of sequential culture of endothelial cells, fibroblasts and cardiomyocytes for formation of vascular cords in cardiac tissue engineering. Biofabrication (2012) 0.82

Generation of tissue constructs for cardiovascular regenerative medicine: from cell procurement to scaffold design. Biotechnol Adv (2012) 0.82

Synthetic oxygen carriers in cardiac tissue engineering. Artif Cells Blood Substit Immobil Biotechnol (2007) 0.81

Hydrogel substrate stiffness and topography interact to induce contact guidance in cardiac fibroblasts. Macromol Biosci (2012) 0.81

Engineered heart tissue model of diabetic myocardium. Tissue Eng Part A (2011) 0.81

QHREDGS enhances tube formation, metabolism and survival of endothelial cells in collagen-chitosan hydrogels. PLoS One (2013) 0.80

Engineering surfaces for site-specific vascular differentiation of mouse embryonic stem cells. Acta Biomater (2009) 0.80

Tissue engineering approaches for the development of a contractile cardiac patch. Future Cardiol (2007) 0.78

Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction. Regen Med (2012) 0.78

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro. Biotechnol Prog (2015) 0.76

Maturation of stem cell-derived human heart tissue by mimicking fetal heart rate. Future Cardiol (2013) 0.76

Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine. Ann N Y Acad Sci (2012) 0.75

Design and fabrication of biological wires. Methods Mol Biol (2014) 0.75

Fusible core molding for the fabrication of branched, perfusable, three-dimensional microvessels for vascular tissue engineering. Int J Artif Organs (2013) 0.75